Genetico

Genetico is one of the largest laboratory and production complexes of international level in Russia, built according to GLP standards, providing a wide range of medical and genetic services for both doctors and patients. The center provides comprehensive genetic diagnostics of inherited diseases and reproductive disorders.
P/E
Net profit
P/B
Book value
Debts
Net debt
Yield
Growth potential

Genetico balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, ₽
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Genetico cash flows

Report period2018 2019 2020 2021 2022
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
EPS

Genetico multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
E/P
P/B
P/S
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Genetico profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Genetico assets
Genetico cash flows

Genetico bonds

NameIssue sizePriceYield
GENETICO BO-01 (RUB)145,000 pcs.99.08%6.61%
GENETICO BO-01 (RUB)145,000 pcs.--
Share capital structure of Genetico
Genetico news
13.12.2023
Genetico's RAS loss for 9 months of 2023 amounted to ₽18.29 million, down 3.2 times from ₽58.84 million in the previous year. Revenue increased 22.3% to ₽250.32 million against ₽204.63 million a year earlier.
18.10.2023
Genetico opened a medical genetics center on the territory of the Technopark of the Moscow Center for Innovative Technologies in Healthcare - Medtech Moscow. Doctors of the center specialize in different areas of medical genetics: reproductive genetics, oncogenetics, cardiogenetics, ophthalmogenetics, genetics of neuromuscular diseases. Center can serve up t...
Source: {source} pictogram t.me
13.10.2023
Genetico submitted documents to Roszdravnadzor to obtain permission to use the Embriotest test developed in Genetico's laboratory for preimplantation genetic testing of embryos for chromosomal abnormalities during IVF, before transferring the embryo into the uterine cavity. According to international studies, the use of PGT increases the efficiency of IVF an...
02.08.2023
Genetico's RAS loss for 6 months of 2023 was ₽28.21 million, down 22.6% from ₽36.43 million in the previous year, with revenue up 9.9% to ₽157.76 million against ₽143.56 million a year earlier.
General information
Company nameGenetico
Tags#ipo2023
SectorHealth Care / Health Care Equipment & Services / Health Care Providers & Services / Health Care Facilities
Business address143026, g. Moskva, territoriya Skolkovo innovacionnogo centra, Bulvar Bolshoy, dom 42, stroenie 1, etazh 1 pom. 334 rab. mes. 52
Mailing address119333, g. Moskva, ul. Gubkina, d. 3, korp.1
CEOIsaev Artur Aleksandrovich
Phone+7 495 646-80-76
Websiteinvestors.genetico.ru
Information disclosuree-disclosure.ru